Join Index

Explore

Streams

Products

About Index

Index

By TNW

Biotechnology

3000+ Companies

Parent markets

Technology

Sibling markets

Related markets

3000+ companies in Biotechnology
Show all

Pfizer Belgium

23andMe

Biotechnology +3

Gilead Sciences

Celgene Corporation

Merck

Amgen Inc.

Manufacturing +2

AbbVie

Biotechnology +1

BiotechZone

GlaxoSmithKline

Health and Wellness +2

Regeneron

Allergan plc

Biotechnology +1

Biogen

Exact Sciences

Biotechnology +1

Roche

Biotechnology +3

Illumina

Biotechnology +2

All companies in Biotechnology

Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing

Built with ❤︎ by Datalicious ©2018
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

Companies

3,090

Booming

Deals 2018 Q3

113 investments

6 acquisitions

Index Pro Account

Upgrade your account to download a CSV export of companies on any list

Upgrade account

Merck bolsters animal health unit with $2.4 billion Antelliq purchase: Reuters

$3,700,000 Venture capital

Seattle biotech startup raises $3.7M to help the body regenerate tissue

Zymergen lands $400 million more for its genetically altered microbes, led by SoftBank Vision Fund

AP heeft sinds invoering EU-privacywet bijna 10.000 privacyklachten ontvangen

$25,600,000 Venture capital (Series B)

,

Synthace Raises $25.6M in Series B Funding

Synthace raises $25.6 million to automate bio labs with software

Aro Biotherapeutics draws $13M in startup investment to target centyrin proteins

Checkmate Pharmaceuticals Closes $22M Financing

Smart Cities Need Intelligent Infrastructure Powered by Smart Energy

WuXi NextCODE tackles genomic sequencing with help from NetApp's Cloud Volumes - SiliconANGLE

Wyss Institute applies "try before you buy" initiative to 3D printed heart valves

Robotics

,

VC-backed 10x Genomics acquires Spatial Transcriptomics

Specialty pharma company Moksha8 adds Garcia-Valiño to board

Roche Vet O’Day Tapped To Shape Gilead’s Future As Hep C Sales Fall

FDA places hold on MacroGenics' bispecific antibody trials over liver toxicity concerns

Venture capital (Series C)

CDH Investments Leads Series C1 Round In AI-Powered Medical Imaging Firm Infervision

Imfinzi looks flimsy in AstraZeneca's Phase III head and neck cancer study

,

VC-backed Moderna Therapeutics goes public

Report: Diagnostics unicorn Grail considering an IPO in the US, possibly next year

$21,000,000 Venture capital (Series B)

,

Kallyope Raises $21M Expansion of Series B Financing